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A b s t r a c t
Background: The use of imaging data fusion method (IDFM) with multislice computed tomography (MSCT) and two-dimensional 
transthoracic echocardiography (2D-TTE) in patients with aortic stenosis (AS) may result in reclassification of AS severity from 
severe to non-severe. 
Aim: We sought to establish potential predictors of AS severity reclassification using the IDFM method. 
Methods: A total of 54 high-risk patients (mean age 79 ± 7.9 years; 40.7% male) with severe AS by 2D-TTE (indexed aortic 
valve area [AVAi] < 0.6 cm2/m2), referred for transcatheter aortic valve implantation, were included in the analysis. AVAi was 
subsequently recalculated using IDFM by replacing 2D-TTE left ventricular outflow tract (LVOT) measurements with MSCT 
LVOT parameters. 
Results: Imaging data fusion method reclassified 20.4% patients into the potentially non-severe AS group. In a multivariable 
model including clinical variables, reclassification to non-severe AS by IDFM was independently associated with younger age 
and diabetes mellitus (DM), (odds ratio [OR] 0.864; 95% confidence interval [CI] 0.76–0.99; p < 0.035 and OR 19.259; 95% 
CI 2.28–162.41; p < 0.007, respectively). In a multivariable analysis of echocardiographic variables, reclassification was associ-
ated with higher LVOT velocity time integral and lower aortic mean gradient (OR 1.402; 95% CI 1.07–1.84; p < 0.014 and 
OR 0.858; 95%: CI 0.760–0.968; p < 0.013, respectively). In addition, 24.1% of patients were reallocated from low-flow 
(< 35 mL/m2) to normal-flow AS. 
Conclusions: Imaging data fusion method reclassified a substantial proportion of patients with severe AS into a potentially 
moderate AS group and from a low-flow to a normal-flow AS group. Such regrouping calls for increased diagnostic prudence 
in AS patients, especially those with specific clinical and echocardiographic predictors of reclassification, such as DM or low 
aortic mean gradient. 
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transcatheter aortic valve implantation
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INTRODUCTION
For more than a decade transcatheter aortic valve implantation 
(TAVI) has been a rescue procedure for patients with severe 
symptomatic aortic stenosis (AS) not suitable for surgical 
aortic valve replacement. The results are encouraging [1, 2]. 
Multimodal imaging of the aortic valve complex in this group 
of patients is a necessity [3, 4]. However, two-dimensional 
transthoracic echocardiography (2D-TTE), two-dimensional 
transoesophageal echocardiography (2D-TEE), three-dimen-
sional TEE (3D-TEE), and multislice computed tomography 
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(MSCT) imaging differ significantly with regard to the precision 
of left ventricular outflow tract (LVOT) [5–7] and aortic annulus 
(AA) [3, 8, 9] measurements, with MSCT considered to be the 
most exact imaging tool [3, 4, 10]. Using the most accurate 
MSCT LVOT size in an imaging data fusion method (IDFM) 
— combining the MSCT LVOT area and 2D-TTE Doppler 
parameters — leads to a recalculation of stroke volume (SV) 
and aortic valve area (AVA), as shown by Kamperidis et al. [8] 
and Clavel et al. [7]. As a result, some patients are reclassified 
as having non-severe rather than severe AS. While potentially 
of significant clinical importance, clinical and anatomical pre-
dictors of such reclassification have not been determined yet. 
METHODS
Patients
A total of 54 high-risk patients with symptomatic severe AS 
(indexed AVA [AVAi] < 0.6 cm2/m2) diagnosed by 2D-TTE 
referred by the local heart team for the TAVI procedure 
(2014–2015) were included in the study. All patients under-
went 2D-TTE and MSCT examinations within a median of 
22 days with no or minor pharmacotherapy interventions 
that should not impact the examination outcomes or IDFM 
calculations. Informed consent for the diagnostic and treat-
ment procedures needed for TAVI was obtained from all 
patients. The study was approved by the local Research Ethics 
Committee. 
Echocardiography 
Echocardiography was carried out according to current 
guidelines [11–13]. The examinations were performed with 
commercially available ultrasound systems (Vivid S70 and E9; 
General Electric Medical Systems, Milwaukee, WI, USA). 
Measurements were done with a dedicated workstation 
(EchoPAC version 201; General Electric Medical Systems). In 
2D-TTE left ventricular (LV) measurements were performed 
in a 2D-mode and LV ejection fraction was assessed with the 
biplane method of disks (modified Simpson’s rule). LVOT and 
AA diameters were measured in long-axis, in zoom mode, 
in mid-systole, in three consecutive cardiac cycles. AA was 
measured first — at hinge-points and distal LVOT as the widest 
diameter just beneath the AA plane — about 3 to 5 mm from 
the AA posterior hinge-point and 1–2 mm from the anterior 
AA hinge-point (Fig. 1A). 
Stroke volume, SV indexed to body surface area (SVi), 
AVA, and AVAi were calculated with the continuity equation. 
High-gradient AS was diagnosed when aortic mean gradient 
(AMG) was higher than 40 mmHg. Patients were classified into 
the low-flow group when calculated SVi, based on 2D-TTE 
Doppler, was < 35 mL/m2. 2D-TEE with 3D-TEE imaging was 
used for confirmation of the diagnosis in low-gradient groups 
and for comparison purposes in high-gradient patients. 
Multislice computed tomography
Multislice computed tomography examinations were performed 
with the use of the Somatom Force device (Siemens Medical 
Solutions, Erlangen, Germany; number of slices: 2 × 192; 
rotation time: 250 ms; kV steps: 70–150 kV; slice thickness: 
0.6 mm). Technical parameters were adjusted to body weight. 
An injection of 45–70 mL of nonionic iodinated contrast agent 
(with 370–400 mgI/mL) at 4–5 mL/s into the antecubital vein 
was administered , followed by a 30-mL saline bolus. Scan data 
were then reconstructed using retrospective electrographic gat-
ing from mid-systole (35%–45% R-R interval). Measurements 
were done with a dedicated Siemens workstation, syngo.via. 
To measure the AA, the double-oblique transverse plain was 
realigned to be perpendicular to the long axis of the aortic 
Figure 1. Left ventricular outflow tract (LVOT) and aortic annulus (AA) assessed using two-dimensional transthoracic echocardio-
graphy (2D-TTE) (A) and multislice computed tomography (MSCT) (B). In 2D-TTE AA was measured at hinge-points (trailing edge 
to leading edge convention) and distal LVOT (inner edge to inner edge convention) as the widest diameter just beneath the AA 
plane. In MSCT AA was manually traced in the plane at the lowest portions of the aortic leaflets and distal LVOT, 5 mm beneath 
the nadirs of the cusps (both in the blood-tissue interface convention)
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root at the lowest portions of the aortic leaflets. At this level, 
AA boundaries were manually traced (Fig. 1B). For distal LVOT 
measurements the transverse plane was set lower, so as to be 
5 mm beneath the nadirs of the cusps. MSCT AA and LVOT 
areas were planimetered and calculated from coronal (maxi-
mal) and sagittal (minimal) diameters using the formula for the 
area of a circle (r was calculated as ½ of the mean diameter). 
Imaging data fusion method
In IDFM, fusion SVi (SVFi) and fusion AVAi (AVAFi) were cal-
culated with a modified continuity equation using Doppler 
LVOT velocity time integral (VTILVOT) derived from 2D-TTE 
and maximum LVOT cross-sectional area derived from MSCT 
measurements. 
Reclassification 
Patients were reclassified to the non-severe AS group when 
AVAi calculated based on IDFM was ≥ 0.6 cm2/m2, and to 
the normal-flow group when SVFi established using IDFM 
was ≥ 35 mL/m2. 
Statistical analysis
Statistical analysis was performed with the IBM SPSS soft-
ware, version 2.0 (SPSS Inc., Chicago, IL, USA). A p-value 
of < 0.05 was considered to be statistically significant. Con-
tinuous data were expressed as mean ± standard deviation, 
and categorical variables as numbers or percentages. The 
association between categorical variables was evaluated with 
the c2 test or Fisher exact test, as appropriate. Continuous 
variables were compared by the paired Student t test. Cor-
relations between continuous variables were established with 
the Pearson test. Bland-Altman analysis was performed to 
determine the bias and the limits of agreement between two 
measurements. In order to find predictors of reclassification, 
an AVAi univariable analysis of clinical and anatomic variables 
was performed with binary logistic regression analysis, and 
variables with a p-value of less than 0.1 were introduced in 
the multivariable models. Individual models were built for 
clinical and imaging parameters (separately for 2D-TTE and 
MSCT), to limit the number of variables in a model. 
RESULTS
Patients
Baseline clinical and echocardiographic characteristics of the 
study group are provided in Tables 1 and 2. 
Overall, 34 (63%) patients were classified as normal-flow 
high-gradient (NFHG), four (7.4%) as normal-flow low-gra-
dient (NFLG), six (11.1%) as low-flow low-gradient (LFLG), 
Table 1. Baseline clinical characteristics of the study subjects  
(n = 54) 
Variable Value
Age [years] 79.9 ± 7.9
Male sex 22 (40.7)
Arterial hypertension 44 (81.5)
BMI [kg/m2] 27.7 ± 5.2
BSA [m2] 1.9 ± 0.2
CAD 35 (64.8)
Previous MI 17 (31.5)
Previous CABG 12 (22.2)
COPD 8 (14.8)
Diabetes mellitus 20 (37.1)
Creatinine level [µmol/L] 101.6 ± 49.8
eGFR [mL/min/1.73 m2] 58.3 ± 2.5
Haemoglobin level [g/dL] 12.5 ± 1.4
NYHA class II 23 (42.6)
NYHA class III 26 (48.1)
NYHA class IV 5 (9.3)
EuroSCORE II [%] 18.8 ± 12.8
Values are presented as mean ± standard deviation or number (per-
centages). BMI — body mass index; BSA — body surface area; CABG 
— coronary artery bypass grafting; CAD — coronary artery disease; 
COPD — chronic obstructive pulmonary disease; eGFR — estimated 
glomerular filtration rate; EuroSCORE — European System for Cardiac 
Operative Risk Evaluation; MI — myocardial infarction; NYHA — New 
York Heart Association
Table 2. Baseline echocardiographic data — 2D-TTE (n = 54) 
Variable Value
APG [mmHg] 86.1 ± 23.8 (31–166)
AMG [mmHg] 52.7 ± 16.3 (19–115)
VTILVOT 22.6 ± 5.4 (11.4-37.0)
VTIAV 114.1 ± 23.3 (56.3-190.9)
SV2D-TTE [mL] 74.2 ± 27.3 (32.4-218.3)
SVi2D-TTE [mL/m
2] 39.8 ± 12.7 (18.3-100.5)
AVA2D-TTE [cm
2] 0.66 ± 0.24 (0.33–2.01)
AVAi2D-TTE [cm
2/m2] 0.36 ± 0.11 (0.20–0.93)
AA [mm] 22.9 ± 2.0 (19–31)
LVOT [mm] 20.3 ± 2.4 (15–30)
LVEF [%] 59.2 ± 11.4 (30–75)
PASP [mmHg] 48.6 ± 15.5 (23–99)
Moderate to severe MR 5 (9.3)
Moderate to severe AR 0 (0)
Low-flow AS 16 (29.6)
Low-gradient AS 11 (20.4)
Data are presented as mean ± standard deviation (range) or number 
(percentage). 2D-TTE — two-dimensional transthoracic echocardio-
graphy; AA — aortic annulus; AMG — aortic mean pressure gradient; 
APG — aortic peak pressure gradient; AR — aortic regurgitation; AS —  
aortic stenosis; AVA2D-TTE — aortic valve area in 2D-TTE; AVAi2D-TTE — 
indexed AVA in 2D-TTE; LVEF — left ventricular ejection fraction; LVOT 
— left ventricular outflow tract; MR — mitral regurgitation; PASP — 
pulmonary artery systolic pressure; SV2D-TTE — stroke volume in 2D-TTE; 
SVi2D-TTE — indexed SV in 2D-TTE; VTIAV — aortic valve velocity time 
integral; VTILVOT — left ventricular outflow tract velocity time integral
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and 10 (18.5%) as low-flow high-gradient (LFHG). Therefore, 
in total the low-flow group consisted of 16 (29.6%) patients. 
Comparison of 2D-TTE and MSCT 
Left ventricular outflow tract measurements performed with 
2D-TTE and MSCT are presented in Table 3. MSCT showed 
the largest LVOT areas. There were moderate correlations 
between the MSCT LVOT mean diameter and the 2D-TTE 
LVOT diameter (r = 0.65, p < 0.001) and moderately strong 
correlations between MSCT LVOT area and 2D-TTE LVOT area 
(r = 0.68, p < 0.001). There were strong correlations between 
SVFi and 2D-TTE SVi (r = 0.79, p < 0.001; Fig. 2A) as well 
as AVAFi and 2D-TTE AVAi (r = 0.76, p < 0.001; Fig. 2B). 
Discordance between 2D-TTE and  
IDFM in SVi and AVAi measurements
The differences in LVOT diameters and areas as measured 
with the two imaging methods translated to differences in 
AVAi (0.36 ± 0.11 cm/m2 vs. 0.50 ± 0.13 cm/m2) and SVi 
(39.8 ± 12.7 mL/m2 vs. 51.1 ± 13.2 mL/m2) calculations 
between 2D-TTE and IDFM, with both AVAi and SVi being 
systematically higher when assessed with IDFM (Fig. 2C, D). 
Correlations between AVAi and AMG  
for 2D-TTE and IDFM 
A statistically significant correlation between AMG and AVAi 
was observed for IDFM but not for 2D-TTE (Fig. 3). 
Reclassification of aortic stenosis  
severity and flow status 
By using AVAFi of ≥ 0.6 cm2/m2 as a cut-off value, 20.4% of 
patients with severe AS in 2D-TTE were reclassified into the 
non-severe AS group (Fig. 4). 
In univariable models, including clinical and imaging data, 
reclassification was independently associated with younger 
age, male sex, coronary artery disease (CAD) with previous 
myocardial infarction (MI), previous coronary artery bypass 
grafting (CABG), diabetes mellitus (DM), and lower aortic 
valve VTI (VTIAV) and AMG values, but with higher values 
of VTILVOT, MSCT planimetered AA area (AAareaMSCTplanimetry), 
minimal MSCT LVOT diameter (LVOTMSCTmin), mean MSCT 
LVOT diameter (LVOTMSCTmean), MSCT planimetered LVOT 
area (LVOTareaMSCTplanimetry), and MSCT LVOT area calculated 
with the pr2 formula (LVOTareaMSCTcirc) (Table 4). 
In a multivariable model including clinical variables, AS 
reclassification was independently associated with age (odds 
ratio [OR] 0.864, 95% confidence interval [CI] 0.76–0.99; 
p < 0.035) and DM (OR 19.259, 95% CI 2.28–162.41; 
p < 0.007). 
In a multivariable model including echocardiographic 
variables, independent predictors of AS reclassification were 
VTILVOT (OR 1.402, 95% CI 1.07–1.84; p < 0.014) and AMG 
(OR 0.858, 95%: CI 0.760–0.968; p < 0.013).
In a multivariable model including MSCT data, LVOT-
MSCTmin was identified as an independent predictors of AS 
reclassification (OR 3.901, 95% CI 1.08–14.16; p < 0.038).
Reclassification from low-flow to normal-flow AS 
Imaging data fusion method reclassified 24.1% of patients 
from a low-flow to a normal-flow AS group. Reclassification 
from severe to non-severe AS by IDFM was accompanied by 
the reclassification from a low-flow to a normal-flow group 
in three out of four patients. In one case, SVFi remained in 
the low-flow range. Six (11.1%) patients in the NFHG group, 
one (1.9%) patient in the NFLG group, three (5.6%) patients 
in the LFLG group, and one in the LFHG group were reclas-
Table 3. Left ventricular outflow tract (LVOT) diameters and areas assessed by two-dimensional transthoracic echocardiography 
(2D-TTE) and multislice computed tomography (MSCT) (n = 54)
Mean SD Minimum Maximum
LVOT diameter [mm]:
LVOT2D-TTE 20.3 2.4 15.0 30.0
LVOTMSCTmin 20.2 2.8 13.0 30.0
LVOTMSCTmax 28.1 3.0 23.0 35.0
LVOTMSCTmean 24.1 2.7 18.0 32.0
LVOT area [mm2]:
LVOTarea2D-TTE 328.9 82.3 176.6 706.5
LVOTareaMSCTplanimetry 460.0 104.7 258.0 738.0
LVOTareaMSCTcirc 464.4 104.0 254.3 803.8
LVOT2D-TTE — left ventricular outflow tract diameter in two-dimensional transthoracic echocardiography; LVOTMSCTmin — LVOT minimal diameter in 
multislice computed tomography; LVOTMSCTmax — LVOT maximal diameter in MSCT; LVOTMSCTmean — LVOT mean diameter in MSCT; LVOTarea2D-TTE — 
LVOT area in 2D-TTE calculated with the pr2 formula for maximal LVOT diameter; LVOTareaMSCTplanimetry — LVOT area planimetered in MSCT;  
LVOTareaMSCTcirc — LVOT area in MSCT calculated with the pr
2 formula for minimal and maximal diameter; SD — standard deviation
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sified to non-severe AS. None of the analysed variables was 
an independent predictor of reclassification from low-flow to 
normal-flow AS group. 
DISCUSSION 
The correct assessment of distal LVOT diameters and area 
in the MSCT enabled the recalculation of SV and AVA in 
IDFM. Similarly to others, we demonstrated that the 2D-TTE 
LVOT diameter (20.3 ± 2.3 mm) actually represented the 
minimal MSCT LVOT diameter (20.2 ± 2.8 mm), yielding 
an underestimation of the 2D-TTE LVOT area, SV, and finally 
AVA [6–8]. The TAVI population was chosen deliberately. All 
patients underwent 2D-TTE, 2D-TEE, 3D-TEE, and MSCT, 
which enabled the comparison of all four imaging methods 
and related our findings to the observations of Kamperidis et 
al. [8] on a TAVI population. We were aware that reclassifi-
cation of AS severity makes sense especially in low-gradient 
groups, but we wanted to test it in all patients to potentially 
establish a new cut-off point for the diagnosis. We preferred 
AVAi, as did Kamperidis et al. [8], because it is a more precise 
parameter than straight AVA and can be used in patients with 
different body weight and height as well as for the purpose 
of comparison between authors. 
In the current study, recalculation of AVAi with IDFM 
resulted in a potential change of the diagnosis from severe to 
non-severe AS in 20.4% of patients. In the study by Kamperidis 
Figure 2. Linear correlations and Bland-Altman analyses of calculations of indexed stroke volume (SVi) and indexed aortic valve 
area (AVAi) on multislice computed tomography (MSCT) and two-dimensional transthoracic echocardiography (2D-TTE). Fusion 
MSCT SVi (MSCT SVFi circ) and AVAi (MSCT AVAFi circ) were calculated with the left ventricular outflow tract area evaluated from 
a maximal and minimal diameter with the pr2 formula, where r was ½ of the mean diameter. Pearson correlations showed high 
agreement between MSCT (MSCT SVFi circ) and 2D-TTE (2D-TTE SVi) calculations of the indexed stroke volume (A) and between 
MSCT (MSCT AVAFi circ) and 2D-TTE (2D-TTE AVAi) calculations of the indexed aortic valve area (B). The Bland-Altman plots 
demonstrate that SVi and AVAi are underestimated by 2D-TTE compared with MSCT (C, D). Echocardiography underestimated 
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Figure 4. Aortic stenosis (AS) severity reclassification with imaging 
data fusion method (IDFM) combining multislice computed 
tomography of the left ventricular outflow tract area and two- 
dimensional transthoracic echocardiography (2D-TTE) Doppler 
parameters. Calculated from a minimal and maximal diameter 
with the pr2 formula, where r was ½ of the mean diameter. 
IDFM reclassified 20.4% of patients into non-severe AS group
Figure 3. Non-linear correlations between aortic mean gradient (AMG) and indexed aortic valve area (AVAi) for two-dimensional 
transthoracic echocardiography (2D-TTE) and multislice computed tomography (MSCT). AVAi was calculated by Doppler echo-
cardiography (2D-TTE AVAi) (A) or by MSCT with the left ventricular outflow tract area evaluated from a maximal and minimal 
diameter with the pr2 formula, where r was ½ of the mean diameter (MSCT AVAFi circ) (B). The correlation between AMG and 
AVAi was better for MSCT AVAFi circ than 2D-TTE AVAi and was statistically significant
et al. [8], 16.2% of TAVI patients were reclassified by IDFM 
(with the same threshold of AVAFi ≥ 0.6 cm2/m2). The differ-
ence might be explained by the fact that Kamperidis et al. [8] 
derived their calculations from the planimetered LVOT area. 
Adopting the same method would have resulted in a nearly 
identical reclassification rate in our study (16%). 
Overall, low-gradient AS was present in approximately 
one in every five patients. This is comparable to other studies 
[14, 15]. In the current study, IDFM reclassified 25% of patients 
from severe to non-severe AS in the NFLG subgroup and as 
much as 33% in the LFLG subgroup when using MSCT LVOT 
planimetered area. These results differ from those reported 
in the study by Kamperidis et al. [8] in which these rates 
were 52% and 11.9%, respectively. The reasons for these 
differences are unclear, but may be partially explained by the 
differences in the body surface areas and 2D-TTE-calculated 
and MSCT-planimetered LVOT areas in the studied popula-
tions. Although in our study the number of patients who were 
reclassified to AVAFi ≥ 0.6 cm2/m2 was highest in the LFLG 
subgroup (even 50% when LVOTareaMSCTcirc was used), IDFM 
reclassified also as many as 17.6% of the NFHG and 10% of the 
LFHG patients. When it was calculated with MSCT-planime-
tered LVOT area the results were 14.7% and 10%, respectively. 
Kamperidis et al. [8] reported much lower rates for the NFHG 
and LFHG groups: 2.8% and 0%, respectively. This may be 
explained by the fact that 2D-TTE and MSCT LVOT areas in 
the NFHG and LFHG groups were apparently larger in the cur-
rent study than in the series by Kamperidis et al. [8], and these 
differences translated to a reclassification of AVAF and AVAFi. 
In comparison, in our study 2D-TEE enabled the reclassifica-
tion of only 3.7% of TAVI patients (with no subjects from the 
low-gradient subgroups) and 3D-TEE reclassified only 11.1% 
of them (with only one [1.9%] patient from the low-gradient 
subgroup). An important conclusion from the current study is 
that reclassification with IDFM may affect not only patients with 
low-gradient AS, but also a considerable number of patients 
with significantly elevated transaortic gradients.
It should be pointed out that the emergence of IDFM 
calls for diagnostic caution in establishing AS severity [7, 16]. 
A B
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Table 4. Predictors of reclassification to moderate aortic stenosis in imaging data fusion method for two-dimensional transthora-
cic echocardiography and multislice computed tomography (MSCT). Univariable model
OR 95% CI p
Age [years] 0.85 0.73–0.98 < 0.029
Male sex [%] 5.52 1.27–24.08 < 0.023
CAD:
with previous MI [%] 5.78 1.40–23.84 < 0.015
with previous CABG [%] 7.40 1.71–32.09 < 0.008
Diabetes mellitus [%] 13.09 2.44–70.12 < 0.003
VTILVOT [cm] 1.14 1.00–1.3 < 0.047
AMG [mmHg] 0.94 0.88–1.0 < 0.036
LVOTMSCTmin [mm] 1.45 1.06–1.98 < 0.019
LVOTMSCTmean [mm] 1.36 1.03–1.80 < 0.032
LVOTareaMSCTcirc [mm
2] 1.01 1.00–1.02 < 0.028
LVOTareaMSCTplanimetry [mm
2] 1.01 1.00–1.01 < 0.047
AAareaMSCTplanimetry [mm
2] 1.01 1.00–1.02 < 0.021
AAareaMSCTplanimetry — aortic annulus area planimetered in MSCT; CI — confidence interval; OR — odds ratio; other abbreviations — see Tables 1 and 2
Jander et al. [17] observed that fusion effective AVA is larger 
than the corresponding anatomic AVA and adjustment of 
partition values may be warranted when using IDFM. Clavel 
et al. [7] proposed a new 1.2-cm2 AVA cut-off point for as-
sessing AS severity in MSCT. Many authors [5, 6] observed 
that non-indexed AVA calculated with IDFM was greater than 
AVA calculated with 2D-TTE, by about 0.1 to 0.2 cm2. In 
our study this difference was 0.15 cm2 (seven patients had 
AVAF ≥ 1.2 cm2 out of 11 patients with AVAFi ≥ 0.6 cm2/m2). 
Clavel et al. [7] noticed significant correlations between AMG 
and non-indexed AVA in a wide range of AVAs (from below 
0.5 to over 3.0 cm2), both for 2D-TTE measurements and 
for IDFM, without significant differences in the correlation 
strength between both methods. In the current study, we 
observed a significant correlation between AMG and AVAFi, 
but this was not true for 2D-TTE. 
In the current study, we determined the predictors of AS 
severity reclassification from severe to moderate. In a univari-
able model the reclassification was independently associated 
with younger age, male sex, CAD with MI, CABG, DM, 
and a lower VTIAV and AMG values as well as higher VTILVOT, 
LVOTMSCTmin diameter, LVOTMSCTmean diameter, LVOTareaMSCTcirc, 
LVOTareaMSCTplanimetry, and AAareaMSCTplanimetry values. In a multi-
variable model AS reclassification was independently associ-
ated with age, DM, VTILVOT, AMG, and MSCT LVOT minimal 
diameter. This calls for caution when establishing the diagnosis 
of severe AS based on 2D-TTE, especially in younger patients 
and diabetics, as well as in those with a higher VTILVOT and lower 
AMG and a relatively larger LVOT. While it is self-explanatory 
that a larger LVOT and higher VTILVOT values are associated 
with a greater risk of reclassification, this is not the case for 
age and DM. The question as to whether the latter is related 
to greater peripheral resistance in diabetic patients remains to 
be established [18].
The imaging data fusion method reclassified nearly 
a quarter of the studied patients from the low-flow to the 
normal-flow AS group. As in the study by Kamperidis at al. [8], 
not every SVi increase above the 35-mL/m2 threshold was 
associated with AVAi reclassification. No specific predictors 
of this reclassification were found. 
Our results represent a single-centre experience. The 
small sample size limited our ability to build complex mul-
tivariable models and subgroup analyses. It seems that the 
validation of IDFM would come from big TAVI registries; with 
a large number of patients the AVAFi cut-off point could be 
established. AVAFi and the predictors of reclassification could 
be matched with short- and long-term survival. 
In summary, IDFM led to the reclassification of AS severity 
from severe to potentially non-severe in approximately one in 
every five patients. Clinical and anatomic predictors of such 
reclassification were established. Reclassification of AVA values 
by IDFM calls for caution but should be considered especially 
in cases of low-gradient AS, i.e. “difficult track” AS, according 
to the recent guidelines [11], particularly in patients in whom 
the probability of AS or flow status reclassification is high. 
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WHAT IS NEW?
The use of the imaging data fusion method (combining two-dimensional transthoracic echocardiography and multislice 
computed tomography [MSCT] parameters) led to the reclassification of aortic stenosis severity from severe to potentially 
non-severe in approximately one in every five patients — including patients with high gradients. Clinical (younger age 
and diabetes mellitus) and anatomic predictors (minimal left ventricular outflow tract diameter on MSCT) of such reclas-
sification were established. Reclassification of aortic valve area values using the imaging data fusion method calls for 
caution but should be considered especially in cases of low-gradient aortic stenosis, i.e. “difficult track” aortic stenosis, 
particularly in patients with a high probability of aortic stenosis severity or flow status reclassification. 
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